Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1982-12-10
1985-06-25
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514258, 514280, 514250, A61K 3148, A61K 31245, A61K 31135
Patent
active
045253595
ABSTRACT:
A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.
REFERENCES:
patent: 2493471 (1950-01-01), Tillitson et al.
patent: 3074847 (1963-01-01), Bigsby
patent: 3422196 (1969-01-01), Thoma et al.
patent: 3808317 (1974-04-01), Hecht et al.
patent: 3818101 (1974-06-01), Baile et al.
patent: 4288433 (1981-09-01), Koulbanis et al.
Chem. Abst., 80, 30,612(v) (1974)-Jenkins et al.
The Merck Index, 9th Edition, 1976, 9 pages.
Goodman & Gilman's, The Pharmacological Basis of Therapeutics, 6th Edition, 1980, Chapter 8, pp. 138 to 154.
Human Fat Cell Metabolism-Effect of Weight Reduction and Regional Differences, Smith, et al., 22 pages.
Metabolism, vol. 28, No. 12, (12/79), Regional Differences in the Control of Kipolysis in Human Adipose Tissue, by J. Ostman, et al., pp. 1198 to 1205.
International Journal of Obesity, 1981, by M. Berlan, et al., Influence of Hypocaloric Diet on-Adrenergic Responsiveness of Obese Human Subcutaneous Adipocytes, pp. 145 to 153.
Journal of Clinical Endocrinology & Metabolism, vol. 53, No. 5, 1981, by P. Arner, et al., Site Differences in the Basal Metabolism of Subcutaneous Fat in Obese Women, pp. 948 to 952.
The New England Journal of Medicine, Jul. 1, 1982, H. Motulsky, et al., Adrenergic Receptors in Man, pp. 18 to 29.
P. Bjorntorp, et al., Human Adipose Tissue Dynamics and Regulation, 1971, pp. 277 to 327.
European Journal of Clinical Investigation, 1979, M. Lafontan, et al., Alpha-adrenergic Antilipolytic Effect of Adrenaline in Human Fat Cells of the Thigh; Comparison with Adrenaline Responsiveness of Different Fat Deposits, pp. 261-266.
Bray George A.
Greenway, III Frank L.
LandOfFree
Treatment for selective weight control does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment for selective weight control, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for selective weight control will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-554177